Skip to content

← All news

Markets

Contineum Therapeutics CEO Stengone sells $41,141 in stock

1 source ·1 article ·Sep 8, 23:32 UTC Contineum Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 8, 23:32 UTC

Contineum Therapeutics CEO Stengone sells $41,141 in stock